Dottikon ES Holding AG
DESN
株式のランク
#3659
Dottikon ES Holding AG manufactures and sells performance chemicals,... Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also offers Dottisol, an isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries. In addition, the company is involved in recycling and waste treatment which includes the recycling, thermal recovery, and high-temperature incineration of waste streams, as well as wastewater treatment and purification activities. Further, it offers chemical custom manufacturing, nitrosamine risk assessment, and containment services; and performance chemicals, including aromatic and alicyclic diamines, bio-based organosilanes, and phlegmatized azides. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. Dottikon ES Holding AG is a subsidiary of EVOLMA Holding AG.
株価
$333.72
時価総額
$4.61B
変化（1日）
-7.20%
変化（1年）
-16.14%
国
CH
取引 Dottikon ES Holding AG (DESN)
カテゴリー
Basic Materials
Dottikon ES Holding AG（DESN）の収益
Mar 2026 時点の収益 TTM: $557.21M
Dottikon ES Holding AG の最新の財務報告によると、現在の収益 (TTM) は $557.21M です。2024 年には $361.62M の収益があり、これは 2023 年の $349.09M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Dottikon ES Holding AG の収益履歴（2005 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $557.21M | 27.88% |
| 2025 | $435.73M | 20.49% |
| 2024 | $361.62M | 3.59% |
| 2023 | $349.09M | 27.93% |
| 2022 | $272.88M | 17.69% |
| 2021 | $231.87M | 27.58% |
| 2020 | $181.74M | 22.45% |
| 2019 | $148.42M | -11.99% |
| 2018 | $168.64M | 9.43% |
| 2017 | $154.11M | 20.33% |
| 2016 | $128.07M | 26.86% |
| 2015 | $100.95M | -2.39% |
| 2014 | $103.42M | 16.82% |
| 2013 | $88.53M | -1.14% |
| 2012 | $89.55M | 2.44% |
| 2011 | $87.42M | -18.43% |
| 2010 | $107.17M | -18.75% |
| 2009 | $131.90M | -7.66% |
| 2008 | $142.84M | 27.10% |
| 2007 | $112.38M | 9.61% |
| 2006 | $102.53M | -8.29% |
| 2005 | $111.80M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $35.45B | 6,261.92% |
GB
|
|
| - | - |
FR
|
|
| $24.41B | 4,280.84% |
US
|
|
| $16.84B | 2,922.67% |
US
|
|
| $12.60B | 2,161.68% |
US
|
